10-101062679-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2
The NM_030929.5(KAZALD1):c.87C>T(p.Gly29Gly) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00273 in 1,544,824 control chromosomes in the GnomAD database, including 91 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.014 ( 39 hom., cov: 33)
Exomes 𝑓: 0.0015 ( 52 hom. )
Consequence
KAZALD1
NM_030929.5 synonymous
NM_030929.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.517
Genes affected
KAZALD1 (HGNC:25460): (Kazal type serine peptidase inhibitor domain 1) This gene encodes a secreted member of the insulin growth factor-binding protein (IGFBP) superfamily. The protein contains an insulin growth factor-binding domain in its N-terminal region, a Kazal-type serine protease inhibitor and follistatin-like domain in its central region, and an immunoglobulin-like domain in its C-terminal region. Studies of the mouse ortholog suggest that this protein may function in bone development and bone regeneration. This gene is hypomethylated and over-expressed in high-grade glioma compared to low-grade glioma, and thus the hypomethylated gene may be associated with cell proliferation and the shorter survival of patients with high-grade glioma. It is also one of numerous genes found to be deleted in a novel 5.54 Mb interstitial deletion, which is associated with multiple congenital anomalies. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -19 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.32).
BP6
Variant 10-101062679-C-T is Benign according to our data. Variant chr10-101062679-C-T is described in ClinVar as [Benign]. Clinvar id is 781215.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.517 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0138 (2105/152358) while in subpopulation AFR AF= 0.0474 (1973/41592). AF 95% confidence interval is 0.0457. There are 39 homozygotes in gnomad4. There are 988 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 39 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KAZALD1 | NM_030929.5 | c.87C>T | p.Gly29Gly | synonymous_variant | 2/5 | ENST00000370200.6 | NP_112191.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KAZALD1 | ENST00000370200.6 | c.87C>T | p.Gly29Gly | synonymous_variant | 2/5 | 1 | NM_030929.5 | ENSP00000359219.6 | ||
KAZALD1 | ENST00000470106.1 | n.44-307C>T | intron_variant | 3 | ||||||
KAZALD1 | ENST00000477979.5 | n.112+564C>T | intron_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.0138 AC: 2098AN: 152240Hom.: 39 Cov.: 33
GnomAD3 genomes
AF:
AC:
2098
AN:
152240
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00337 AC: 484AN: 143712Hom.: 13 AF XY: 0.00227 AC XY: 181AN XY: 79814
GnomAD3 exomes
AF:
AC:
484
AN:
143712
Hom.:
AF XY:
AC XY:
181
AN XY:
79814
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00152 AC: 2112AN: 1392466Hom.: 52 Cov.: 32 AF XY: 0.00134 AC XY: 921AN XY: 689014
GnomAD4 exome
AF:
AC:
2112
AN:
1392466
Hom.:
Cov.:
32
AF XY:
AC XY:
921
AN XY:
689014
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0138 AC: 2105AN: 152358Hom.: 39 Cov.: 33 AF XY: 0.0133 AC XY: 988AN XY: 74502
GnomAD4 genome
AF:
AC:
2105
AN:
152358
Hom.:
Cov.:
33
AF XY:
AC XY:
988
AN XY:
74502
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
6
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 16, 2018 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at